Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). (Q42952248)
Jump to navigation
Jump to search
scientific article published on August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). |
scientific article published on August 2010 |
Statements
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) (English)
Stefan K James
Michail Koutouzis
Bo Lagerqvist
Ulf Stenestrand
Bodil Svennblad
Jonas Oldgren
1 August 2010